Significance of the absolute number and ratio of metastatic lymph nodes in predicting postoperative survival for the International Federation of Gynecology and Obstetrics stage IA2 to IIA cervical cancer

International Journal of Gynecological Cancer

Volumn 23, Issue 1, 2013, Pages 157-163

  Chen, Ying ^a   Zhang, Lei ^a   Tian, Jing ^a   Fu, Xin ^a   Ren, Xiubao ^a   Hao, Quan ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Cervical cancer; Lymph node metastasis; Pelvic lymphadenectomy; Prognosis; Radical hysterectomy

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NUMBER OF METASTATIC LYMPH NODE; ONCOLOGICAL PARAMETERS; PELVIS LYMPHADENECTOMY; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; RATIO OF METASTATIC AND REMOVED LYMPH NODE; RETROSPECTIVE STUDY; UTERINE CERVIX CANCER;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; GYNECOLOGY; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; OBSTETRICS; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR BURDEN; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84872320862     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e3182778bcf     Document Type: Article

References (27)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Sevin BU, Nadji M, Lampe B, et al. Prognostic factors in early stage cervical carcinoma treated with radical hysterectomy. Cancer. 1995;76:1978-1986.
3. Tseng JY, Yen MS, Twu NF, et al. Prognostic nomogram for overall survival in stage IIB-IVA cervical cancer patients treated with concurrent chemoradiotherapy. Am J Obstet Gynecol. 2010;202:174.e1-174.e7.
4. Delgado G, Bundy B, Zaino R, et al. Prospective surgical-pathological study of disease free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol. 1990;38:352-357.
5. Hosaka M, Watari H, Mitamura T, et al. Survival and prognosticators of node-positive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy. Int J Clin Oncol. 2011;16:33-38.
6. Chan JK, Kapp DS, Cheung MK, et al. The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients. Br J Cancer. 2007;97:605-611.
7. Wilson M, Rosato EL, Chojnacki KA, et al. Prognostic significance of lymph node metastases and ratio in esophageal cancer. J Surg Res. 2008;146:11-15.
8. Nigro JJ, DeMeester SR, Hagen JA, et al. Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg. 1999;117:960-968.
9. Bollschweiler E, Baldus SE, Schröder W, et al. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors? J Surg Oncol. 2006;94:355-363.
10. Horn LC, Hentschel B, Galle D, et al. Extracapsular extension of pelvic lymph node metastases is of prognostic value in carcinoma of the cervix uteri. Gynecol Oncol. 2008;108:63-67.
11. Polterauer S, Hefler L, Seebacher V, et al. The impact of lymph node density on survival of cervical cancer patients. Br J Cancer. 2010;103:613-616.
12. Metindir J, Bilir G. Impact of the ratio of metastatic to examined lymph nodes on the survival of early-stage cervical cancer patients. Onkologie. 2009;32:103-106.
13. Kim HS, Kim JH, Chung HH, et al. Significance of numbers of metastatic and removed lymph nodes in FIGO stage IB1 to IIA cervical cancer: primary surgical treatment versus neoadjuvant chemotherapy before surgery. Gynecol Oncol. 2011;121:551-557.
14. Crum CP, Lee KR. Diagnostic Gynecologic and Obstetric Pathology. 1 ed. Philadelphia PA, USA: Elsevier Saunders; 2006.
15. Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol. 2005;23:7114-7124.
16. Kodama J, Seki N, Masahiro S, et al. Prognostic factors in stage IB-IIB cervical adenocarcinoma patients treated with radical hysterectomy and pelvic lymphadenectomy. J Surg Oncol. 2010;101:413-417.
17. Kasamatsu T, Onda T, Sawada M, et al. Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation. Gynecol Oncol. 2009;114:69-74.
18. Takeda N, Sakuragi N, Takeda M, et al. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand. 2002;81:1144-1151.
19. Tsai CS, Lai CH, Wang CC, et al. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy. Gynecol Oncol. 1999;75:328-333.
20. Lai CH, Hong JH, Hsueh S, et al. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of stage IB or II cervical carcinoma patients with or without pelvic lymph node metastasis. Cancer. 1999;85:1537-1546.
21. Sakuragi N, Satoh C, Takeda N, et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in stages IB, IIA and IIB cervical carcinoma treated with radical hysterectomy. Cancer. 1999;85:1547-1554.
22. Berger AC, Sigurdson ER, LeVoyer T, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2005;23:8706-8712.
23. Kassouf W, Agarwal PK, HerrHW, et al. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. J Clin Oncol. 2008;26:121-126.
24. Vinh-Hung V, Verkooijen HM, Fioretta G, et al. Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol. 2009;27:1062-1068.
25. Yamashita K, Ooki A, Sakuramoto S, et al. Lymph node metastasis density (ND)Yfactor association with malignant degree and ND40 as 'non-curative factor' in gastric cancer. Anticancer Res. 2008;28:435-441.
26. Bando E, Yonemura Y, Taniguchi K, et al. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol. 2002;9:775-784.
27. Trattner M, Graf AH, Lax S, et al. Prognostic factors in surgically treated stage Ib-IIb cervical carcinomas with special emphasis on the importance of tumor volume. Gynecol Oncol. 2001;82:11-16.